Cogent Biosciences
COGT
COGT
44 hedge funds and large institutions have $212M invested in Cogent Biosciences in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
9.35% less ownership
Funds ownership: 22.23% → 12.88% (-9.3%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
44
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$17.9M | |
| 2 | +$6.4M | |
| 3 | +$2.24M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.49M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$771K |
Top Sellers
| 1 | -$3.77M | |
| 2 | -$2.78M | |
| 3 | -$2.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.5M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.94M |